Strontium-89 (Metastron)

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

General information

Radioactive strontium

Diseases for which it was used

History of changes in FDA indication

  • 1993-06-18: Initial approval for the relief of bone pain in patients with painful skeletal metastases.

History of changes in PMDA indication

  • 2007-07-31: Initial approval for pain relief in bone scintigraphy-positive metastatic lesions in patients with solid cancers.

Also known as

  • Brand name: Metastron